Antiparasitic activity of risedronate in a murine model of acute Chagas’ disease
- 1 March 2004
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (3) , 286-290
- https://doi.org/10.1016/j.ijantimicag.2003.07.019
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2002
- A Critical Review on Chagas Disease ChemotherapyMemórias do Instituto Oswaldo Cruz, 2002
- Specific treatment of Chagas disease: current status and new developmentsCurrent Opinion in Infectious Diseases, 2001
- Bisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate SynthasePublished by Elsevier ,2001
- Recent Developments in the Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2001
- The acidocalcisomeMolecular and Biochemical Parasitology, 2001
- Bisphosphonates Inhibit the Growth ofTrypanosomabrucei,Trypanosomacruzi,Leishmaniadonovani,Toxoplasmagondii, andPlasmodiumfalciparum: A Potential Route to ChemotherapyJournal of Medicinal Chemistry, 2001
- Therapeutic Approaches to Bone DiseasesScience, 2000
- Acidocalcisome: A Novel Ca2+ Storage Compartment in Trypanosomatids and Apicomplexan ParasitesParasitology Today, 1999
- Trypanosoma cruzi Contains Major Pyrophosphate Stores, and Its Growth in Vitro and in Vivo Is Blocked by Pyrophosphate AnalogsJournal of Biological Chemistry, 1999